Search for: "Eli Lilly "
Results 1121 - 1140
of 2,131
Sorted by Relevance
|
Sort by Date
13 May 2014, 9:23 am
"All this is compliant with the GAT and Folien decisions and the Corte di Cassazione ruling, as well the UK decision in Joined cases Actavis Group hf v Eli Lilly & Company (USA) and Medis ehf v Eli Lilly & Company (USA) [here]. [read post]
29 Jan 2018, 2:57 am
The UCL debate on the UK Supreme Court decision Actavis v Eli Lilly ("Equivalents: K = Na. [read post]
6 Apr 2018, 8:03 am
The Court of Appeal heard arguments regarding whether, if they had accepted Kymab's construction of "in situ replacement", they could nevertheless have found infringement on the basis of Actavis v Eli Lilly (Eli Lilly v Actavis UK [2017] UKSC 48, IPKat post). [read post]
18 Nov 2018, 7:39 am
In her comment Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in Icescape v Ice-World, InternKat Rose analyses this recent case to determine whether Lord Kitchin approached any of the unresolved issues left in the Actavis v Eli Lilly case.CopyrightLast year The IPKat reported on two new important referrals to the Court of Justice of the European Union (CJEU) from Germany. [read post]
15 Apr 2017, 4:17 am
Tune in LIVE for tomorrow's Eli Lilly v Actavis Supreme Court showdownThe Supreme Court was live online to hear Tom Mitcheson QC (supported by Andrew Waugh QC and leading Stuart Baran) for Eli Lilly against Danny Alexander QC (leading Thomas Raphael QC) for Actavis.Oldie but goldie - when is old prior art a suitable starting point for inventive step analysis? [read post]
23 Jul 2009, 7:00 am
Paterson, Assembly Speaker Sheldon Silver, Eli Lilly and Company CEO Dr. [read post]
16 Sep 2008, 4:35 am
Rochester's argument about Lilly is rejected at page 924: Rochester's suggestion in its brief that Lilly "compounded Ruschig's error" by "invoking the written description requirement in a case without priority issues" is similarly deficient. [read post]
23 Jul 2010, 1:54 pm
Eli Lilly Canada v. [read post]
18 Jun 2009, 8:17 am
Long Island Railroad, finding that because there was no direct connection between Eli Lily's warnings and the victim, finding a duty from Lilly to decedent would be tantamount to Lily owing a duty to everyone. [read post]
18 Jun 2009, 8:17 am
Long Island Railroad, finding that because there was no direct connection between Eli Lily's warnings and the victim, finding a duty from Lilly to decedent would be tantamount to Lily owing a duty to everyone. [read post]
17 Sep 2010, 7:33 am
Eli Lilly and Company, __ F.3d __, 2010 WL 3516183 (2d Cir. [read post]
9 Apr 2009, 7:52 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent Infringement Updates) (Patently-O) (Patent Docs) Xigris (Drotrecogin alfa) –US: CAFC: Pioneering claims require more expansive written description: Ariad v… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
3 Mar 2008, 9:27 pm
" Eli Lilly, 119 F.3d at 1568, 43 USPQ2d at 1406. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
17 Feb 2018, 7:30 am
”Henry loved when he was in "shear mode"Claim "Interpretation" - it is all about what you say and disclaimWith the old "Construction" heading now replaced with "Interpretation", Mr Justice Carr stated he would be applying"principles concerning normal interpretation and equivalents set out by the Supreme Court in Actavis v Eli Lilly [2017] UKSC 48, [2018] and by the Patents Court in Mylan v Yeda [2017] EWHC 2629 (Pat) at [134]… [read post]
29 Jun 2015, 9:36 am
In the brand-new Court of Appeal decision just out - Actavis UK Ltd & Others v Eli Lilly & Company [2015] EWCA Civ 555 (25 June 2015), Lord Justice Floyd (Lords Justices Kitchin and Longmore concurring) disagreed with Arnold J on two main issues. [read post]
23 Feb 2016, 1:53 am
Mrs Justice Rose is go go go in Lilly v Janssen stay applicationStays of proceedings are not easy in UK courts, as Janssen found out last week in Eli Lilly v Janssen Sciences [2016] EWHC 313, where Mrs Justice Rose refused to stay Lilly's revocation and declaration of non-infringement (DNI) action brought against Janssen's divisional patent - EP (UK) 2 305 282. [read post]
18 Aug 2017, 5:56 am
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
8 Aug 2017, 12:10 pm
UK Supreme Court moves towards a UK Doctrine of Equivalents in Lilly pemetrexed battle? [read post]
